CaMKIβ Activators
CaMKIβ Activators are a diverse range of compounds that influence the protein's function through various mechanisms, primarily related to the modulation of intracellular calcium levels and cAMP-dependent signaling pathways. Calcium is a key activator of CaMKIβ and many of these compounds work by facilitating calcium influx or inhibiting calcium efflux, thereby increasing intracellular calcium concentrations. For instance, A23187 and Thapsigargin are potent tools for increasing intracellular calcium levels, which in turn leads to CaMKIβ activation. Similarly, Nifedipine, Bay K 8644, and Verapamil mediate their actions through interaction with calcium channels, indirectly leading to heightened intracellular calcium levels and subsequent CaMKIβ activation.
The role of cAMP-dependent signaling in the function of CaMKIβ is highlighted by the action of compounds such as Forskolin and IBMX. These compounds enhance the intracellular levels of cAMP, leading to the activation of Protein Kinase A (PKA). PKA can phosphorylate and activate CaMKIβ, linking cAMP-dependent signaling to the functional activity of CaMKIβ. Isoproterenol, a beta-adrenergic agonist, also operates on this pathway by stimulating adenylyl cyclase and increasing cAMP levels. Finally, some compounds such as Chelerythrine Chloride and Calmidazolium Chloride operate by inhibiting competing signaling pathways or through feedback mechanisms, ultimately leading to CaMKIβ activation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, which increases intracellular levels of cyclic AMP (cAMP). The rise in cAMP triggers the activation of Protein Kinase A (PKA). PKA in turn phosphorylates and activates CaMKIβ. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, which leads to an increase in intracellular cAMP levels. The elevated cAMP can activate PKA, which then phosphorylates and activates CaMKIβ. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased intracellular calcium levels. The elevated calcium concentrations activate calmodulin, which then activates CaMKIβ. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a mobile ion carrier that transports calcium across biological membranes, leading to increased intracellular calcium levels. The increase in calcium activates calmodulin, which subsequently activates CaMKIβ. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine is a calcium channel blocker that can indirectly increase intracellular calcium levels via feedback mechanisms. The increase in calcium activates calmodulin, which then activates CaMKIβ. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Bay K 8644 is an L-type calcium channel agonist that increases intracellular calcium levels. The elevated calcium concentrations activate calmodulin, which subsequently activates CaMKIβ. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil is a calcium channel blocker that can indirectly increase intracellular calcium levels via feedback mechanisms. The elevated calcium levels activate calmodulin, which subsequently activates CaMKIβ. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that stimulates adenylyl cyclase, thereby increasing intracellular cAMP levels. The elevated cAMP activates PKA, which then phosphorylates and activates CaMKIβ. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Ryanodine modulates intracellular calcium release channels, increasing intracellular calcium levels. The elevated calcium levels activate calmodulin, which then activates CaMKIβ. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
Chelerythrine Chloride inhibits Protein Kinase C (PKC), leading indirectly to increased intracellular calcium levels. The increased calcium levels activate calmodulin, which subsequently activates CaMKIβ. | ||||||